
New cancer treatment shows chances of improved survival rates for rare and aggressive cancer
#Cancer, #CancerTreatment IBNS-CMEDIA; The phase 3 clinical trial, published recently in JAMA Oncology and sponsored by Polaris Pharmaceuticals, has unveiled a breakthrough in the treatment of malignant pleural mesothelioma (MPM), a …
Read More